Crossmark

A novel apolipoprotein E mutation, ApoE Ganzhou (Arg43Cys), in a Chinese son and his father with lipoprotein glomerulopathy: two case reports

Published Online: 2022-02-23

Published Print: 2022-12

Authors

Wang, Runxiu

Zhao, Chengbo

Chen, Wen

Liu, Zhiping

Xie, Fuhua https://orcid.org/0000-0003-2512-394X
Funding

Funding for this research was provided by:

Youth Science Foundation of Jiangxi Province (GJJ170866)

BC Renal Agency (20165348)
License Information

Text and Data Mining valid from 2022-02-23

Version of Record valid from 2022-02-23
More Information

Article History

Received: 25 August 2021

Accepted: 31 January 2022

First Online: 23 February 2022

Declarations

:

: The case was established according to the ethical guidelines of the Helsinki Declaration and approved by the Human Ethics Committee of Gannan Medical University. Written informed consent was obtained from patients or guardians.

: Written informed consent was obtained from the patients for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

: The authors declare that they have no competing interests.

Document is current